BOSTON ADVISORS LLC - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 190 filers reported holding IMPAX LABORATORIES INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOSTON ADVISORS LLC ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$737,000
+60.2%
37,905
+37.2%
0.02%
+90.0%
Q4 2017$460,000
-15.3%
27,635
+3.3%
0.01%
-16.7%
Q3 2017$543,000
+59.7%
26,750
+127.0%
0.01%
+50.0%
Q2 2016$340,000
-8.8%
11,785
+1.1%
0.01%
-11.1%
Q1 2016$373,000
-25.3%
11,6600.0%0.01%
-25.0%
Q4 2015$499,00011,6600.01%
Other shareholders
IMPAX LABORATORIES INC shareholders Q1 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 423,161$13,406,0007.47%
Aravt Global 2,300,000$72,864,0005.43%
Slate Path Capital LP 2,330,000$73,814,0005.16%
Orbimed Advisors 6,678,000$211,559,0002.02%
Iguana Healthcare Management, LLC 100,000$3,168,0001.53%
Iguana Healthcare Management, LLC 100,000$3,168,0001.53%
Penn Capital Management Company, LLC 709,045$22,463,0000.94%
HUSSMAN STRATEGIC ADVISORS, INC. 250,000$7,920,0000.79%
NEW AMSTERDAM PARTNERS LLC/NY 276,169$8,749,0000.76%
Matarin Capital Management, LLC 52,932$1,676,886,0000.74%
View complete list of IMPAX LABORATORIES INC shareholders